Özcan Met Selected Research

Özcan Met Research Topics

Disease

52	Neoplasms (Cancer) 01/2024 - 08/2012
19	Melanoma (Melanoma, Malignant) 01/2023 - 08/2012
4	Ovarian Neoplasms (Ovarian Cancer) 11/2020 - 01/2018
2	Sarcoma (Soft Tissue Sarcoma) 01/2024 - 11/2020
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2021 - 01/2018
2	Hypersensitivity (Allergy) 01/2020 - 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Tetanus 01/2023
1	Human Influenza (Influenza) 01/2023
1	Body Weight (Weight, Body) 12/2022
1	COVID-19 10/2022
1	Disease Progression 01/2022
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022
1	Basal Cell Carcinoma (Rodent Ulcer) 02/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2021
1	Philadelphia Chromosome 01/2021
1	Multiple Myeloma 01/2020
1	Injection Site Reaction 01/2020
1	Lymphoma (Lymphomas) 03/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Ascites 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2017

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 01/2024 - 06/2013
13	Peptides (Polypeptides)IBA 01/2023 - 01/2015
12	EpitopesIBA 01/2023 - 03/2013
10	AntigensIBA 01/2023 - 01/2014
8	CytokinesIBA 01/2023 - 01/2013
7	EnzymesIBA 01/2023 - 01/2015
6	Messenger RNA (mRNA)IBA 10/2022 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2019
5	Interleukin-2 (IL2)IBA 01/2023 - 08/2012
4	LigandsIBA 01/2021 - 03/2013
4	Chemokine ReceptorsIBA 01/2018 - 06/2013
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 01/2020
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
3	IpilimumabIBA 12/2022 - 06/2020
3	Cancer VaccinesIBA 10/2022 - 01/2017
3	Arginine (L-Arginine)FDA Link 10/2022 - 01/2018
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 01/2021 - 01/2014
3	ChemokinesIBA 01/2018 - 01/2016
3	InterleukinsIBA 01/2015 - 08/2012
2	InterferonsIBA 01/2023 - 01/2015
2	cyclopropapyrroloindoleIBA 01/2023 - 01/2020
2	Blocking AntibodiesIBA 03/2022 - 02/2021
2	CalreticulinIBA 01/2022 - 01/2021
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021 - 01/2018
2	Chimeric Antigen ReceptorsIBA 10/2019 - 03/2019
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018 - 03/2013
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2016 - 05/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 06/2013
1	LTX-315IBA 01/2024
1	Death Domain ReceptorsIBA 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	interleukin-21 (interleukin 21)IBA 01/2023
1	CTLA-4 AntigenIBA 12/2022
1	mRNA VaccinesIBA 10/2022
1	ChromiumIBA 10/2022
1	HLA-B8 Antigen (HLA B8 Antigen)IBA 10/2022
1	Programmed Cell Death 1 ReceptorIBA 03/2022
1	Galectin 3 (LGALS3)IBA 01/2022
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022
1	IntegrinsIBA 10/2021
1	NivolumabIBA 10/2021
1	Protein Subunit VaccinesIBA 01/2021
1	ThioredoxinsIBA 01/2021
1	VemurafenibIBA 01/2021
1	Monatide (IMS 3015)IBA 01/2021
1	Zoledronic Acid (Zometa)FDA Link 01/2021
1	Recombinant ProteinsIBA 01/2021
1	RNA (Ribonucleic Acid)IBA 11/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Immune Checkpoint ProteinsIBA 01/2020
1	c-Mer Tyrosine KinaseIBA 09/2019
1	ProlactinIBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Aromatase (CYP19)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Peptide LibraryIBA 01/2018
1	Protein Sorting Signals (Signal Peptide)IBA 01/2018
1	Docetaxel (Taxotere)FDA Link 01/2017
1	S-1,2-dichlorovinyl-N-acetylcysteineIBA 01/2017
1	Amino Acids FDA Link 08/2016
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016
1	Chemokine CCL22IBA 01/2016
1	Monophenol Monooxygenase (Tyrosinase)IBA 05/2015
1	HLA-A1 Antigen (HLA A1 Antigen)IBA 05/2015
1	DioxygenasesIBA 01/2015
1	Heme (Haem)IBA 01/2015
1	Interleukin-10 (Interleukin 10)IBA 01/2015

Therapy/Procedure

16	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2024 - 08/2012
16	Therapeutics 01/2024 - 08/2012
16	Immunotherapy 01/2023 - 01/2013
2	Immunomodulation 10/2022 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2020
1	Radiotherapy 01/2023
1	Castration 01/2017